https://www.novumpr.nl/2019/09/08/ipsen-and-servier-announce-initial-phase-ii-iii-clinical-data-evaluating-investigational-liposomal-irinotecan-onivyde-as-a-second-line-treatment-for-small-cell-lung-cancer-sclc-at-the-iaslc/?utm_source=rss&utm_medium=rss&utm_campaign=ipsen-and-servier-announce-initial-phase-ii-iii-clinical-data-evaluating-investigational-liposomal-irinotecan-onivyde-as-a-second-line-treatment-for-small-cell-lung-cancer-sclc-at-the-iaslc NovumPR press releases Mon, 09 Sep 2019 06:20:21 +0000 hourly 1 https://wordpress.org/?v=6.8.3